AstraZeneca
AZN
#44
Rank
C$403.02 B
Marketcap
C$259.97
Share price
-0.79%
Change (1 day)
18.16%
Change (1 year)

AstraZeneca (AZN) - P/B ratio

P/B ratio as of March 2026 : 5.99

According to AstraZeneca's latest financial reports the company has a price-to-book ratio of 5.02341.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

AstraZeneca - P/B ratio (from 2001 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-316.2625.7%
2024-12-314.98-6.72%
2023-12-315.34-5.93%
2022-12-315.6822.91%
2021-12-314.62-44.86%
2020-12-318.38-6.58%
2019-12-318.9733.36%
2018-12-316.7228.42%
2017-12-315.2426.54%
2016-12-314.14-11.43%
2015-12-314.672.46%
2014-12-314.5643.05%
2013-12-313.1930.18%
2012-12-312.45-5.1%
2011-12-312.58-7.22%
2010-12-312.78-15.01%
2009-12-313.27-11.54%
2008-12-313.70-11.59%
2007-12-314.18-21.39%
2006-12-315.32-6.66%
2005-12-315.7038.15%
2004-12-314.13-33.21%
2003-12-316.1815.01%
2002-12-315.37

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Johnson & Johnson
JNJ
7.00 16.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
6.25 4.32%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
1.64-72.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
3.71-38.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
30.8 413.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.21-79.76%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
1.46-75.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
5.43-9.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
6.49 8.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
4.91-18.01%๐Ÿ‡ฌ๐Ÿ‡ง UK